IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

VIGNATI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.613
AS - Asia 7.399
NA - Nord America 6.292
SA - Sud America 911
AF - Africa 154
OC - Oceania 81
Continente sconosciuto - Info sul continente non disponibili 1
Totale 22.451
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.996
IT - Italia 3.344
SG - Singapore 2.278
CN - Cina 2.141
GB - Regno Unito 868
HK - Hong Kong 845
BR - Brasile 654
DE - Germania 643
RU - Federazione Russa 511
NL - Olanda 501
VN - Vietnam 449
FR - Francia 403
BD - Bangladesh 379
SE - Svezia 358
JP - Giappone 314
IN - India 300
CA - Canada 175
IE - Irlanda 162
FI - Finlandia 145
KR - Corea 128
TR - Turchia 122
ID - Indonesia 113
ES - Italia 86
DK - Danimarca 74
MX - Messico 68
CO - Colombia 67
AU - Australia 66
PL - Polonia 65
AT - Austria 62
AR - Argentina 59
CH - Svizzera 50
CI - Costa d'Avorio 50
CL - Cile 47
BE - Belgio 44
PH - Filippine 44
UA - Ucraina 43
GR - Grecia 41
PT - Portogallo 37
IQ - Iraq 33
CZ - Repubblica Ceca 32
TW - Taiwan 30
EC - Ecuador 28
ZA - Sudafrica 27
HR - Croazia 26
NO - Norvegia 25
PK - Pakistan 25
TH - Thailandia 25
SA - Arabia Saudita 22
RO - Romania 20
UZ - Uzbekistan 20
AE - Emirati Arabi Uniti 19
EG - Egitto 18
UY - Uruguay 18
VE - Venezuela 18
IL - Israele 17
IR - Iran 16
MY - Malesia 16
NZ - Nuova Zelanda 15
BG - Bulgaria 14
MA - Marocco 14
NG - Nigeria 11
LV - Lettonia 10
NP - Nepal 10
PE - Perù 10
JO - Giordania 9
KZ - Kazakistan 9
DO - Repubblica Dominicana 8
HU - Ungheria 8
LT - Lituania 8
TN - Tunisia 8
AZ - Azerbaigian 7
EU - Europa 7
RS - Serbia 7
AL - Albania 6
CR - Costa Rica 6
ET - Etiopia 6
BO - Bolivia 5
GT - Guatemala 5
HN - Honduras 5
KE - Kenya 5
PA - Panama 5
PY - Paraguay 5
DZ - Algeria 4
EE - Estonia 4
JM - Giamaica 4
LK - Sri Lanka 4
LU - Lussemburgo 4
NI - Nicaragua 4
OM - Oman 4
PR - Porto Rico 4
TT - Trinidad e Tobago 4
BB - Barbados 3
MK - Macedonia 3
SC - Seychelles 3
YE - Yemen 3
AG - Antigua e Barbuda 2
BH - Bahrain 2
GA - Gabon 2
KH - Cambogia 2
LB - Libano 2
Totale 22.428
Salva come PNG Salva come JPEG
Città #
Singapore 1.210
Ashburn 759
Hong Kong 735
Southend 597
San Jose 534
Milan 531
Chandler 386
Dallas 318
Beijing 313
Frankfurt am Main 291
Council Bluffs 268
Hefei 260
Rome 241
Los Angeles 221
New York 193
Princeton 193
Santa Clara 185
Dublin 163
Bengaluru 149
Fairfield 144
Venice 142
Lauterbourg 135
Ho Chi Minh City 129
Ann Arbor 118
Buffalo 118
Wilmington 117
Hanoi 106
Seattle 104
Cambridge 93
Moscow 91
Seoul 88
Redwood City 86
Des Moines 85
Tokyo 80
Helsinki 79
Houston 79
Naples 79
São Paulo 76
Jakarta 75
Shanghai 70
Guangzhou 68
Boardman 66
Woodbridge 62
Florence 58
Munich 57
Tianjin 52
Abidjan 50
Jinan 49
Istanbul 47
Cangzhou 44
Nuremberg 44
Nanjing 43
London 42
Padova 42
Monza 41
Phoenix 41
Turin 41
Brasília 40
Rio de Janeiro 40
Changsha 39
Shenzhen 38
Medford 37
Chions 36
Zhengzhou 34
Atlanta 33
Bologna 33
Groningen 33
Columbus 32
Genoa 32
Montreal 32
Warsaw 32
Amsterdam 31
Lappeenranta 31
Mumbai 31
Fuzhou 30
Palermo 30
Shenyang 30
Stockholm 30
Toronto 30
Brussels 29
Chicago 29
Sydney 28
Pisa 27
Central District 26
Paris 26
The Dalles 26
Berlin 25
Dearborn 25
Vienna 25
Catania 24
Santiago 24
Basingstoke 23
Orem 23
Brescia 22
Da Nang 22
Bogotá 21
Hangzhou 21
San Diego 21
Washington 21
Zagreb 21
Totale 11.731
Salva come PNG Salva come JPEG
Nome #
Ventilazione ed esercizio (normale e patologico) 1.686
Reference values for peak exercise cardiac output in healthy individuals 678
Anaerobic Threshold and Respiratory Compensation Point Identification During Cardiopulmonary Exercise Tests in Chronic Heart Failure 484
You can leave your mask on : Effects on cardiopulmonary parameters of different airway protection masks at rest and during maximal exercise 422
Relationship of resting hemoglobin concentration to peak oxygen uptake in heart failure patients 398
Cardiovascular death risk in recovered mid-range ejection fraction heart failure: insights from cardiopulmonary exercise test 384
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment : Results from the Mecki score dataset 357
Exercise performance, haemodynamics, and respiratory pattern do not identify heart failure patients who end exercise with dyspnoea from those with fatigue 336
X-ray exposure in cardiac electrophysiology: A retrospective analysis in 8150 patients over 7 years of activity in a modern, large-volume laboratory 293
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 281
Pick Your Threshold: A Comparison Among Different Methods of Anaerobic Threshold Evaluation in Heart Failure Prognostic Assessment 278
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 278
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 269
Il CPET nella diagnostica della dispnea: respiratoria o cardiaca? Metodologia ed interpretazione dei risultati 266
Deceived by the Fick principle: blood flow distribution in heart failure 255
Beyond VO2: the complex cardiopulmonary exercise test 249
Fisiopatologia del cuore : un progetto di collaborazione tra studenti di medicina e docenti 234
Cardiac output changes during exercise in heart failure patients: focus on mid-exercise 219
Does moderate hyperkalemia influence survival in HF? Insights from the MECKI score data base 210
The chronic heart failure evolutions: Different fates and routes 199
MULTIDISCIPLINARY MANAGEMENT IN A CASE OF EOSINOPHILIC MYOCARDITIS WITH CHURG STRAUSS SYNDROME: FROM ECG TO ENDOMYOCARDIAL BIOPSY 196
Predictors of prognosis in patients with secondary mitral regurgitation undergoing mitral valve transcatheter edge-to-edge repair 195
Integrating pulmonary function testing with cardiopulmonary exercise testing for enhanced stratification in hypertrophic cardiomyopathy 194
Heart failure patients with improved ejection fraction: insights from the MECKI Score database 185
Early cardiac reverse remodelling in a large cohort of patients with HFrEF treated with Sacubitril/Valsartan 184
Sacubitril/valsartan use in a real world experience: data from a large single-center population of heart failure patients with reduced ejection fraction 182
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 177
Validazione di un nuovo device indossabile di monitoraggio cardiorespiratorio : il futuro dell'holter e polisonnografia? 176
Minute ventilation/carbon dioxide production in chronic heart failure 175
A case of myopericarditis recurrence after third dose of BNT162b2 vaccine against SARS-CoV-2 in a young subject: link or causality? 171
Impact of Sacubitril/Valsartan on surfactant binding proteins, central sleep apneas, lung function tests and heart failure biomarkers: Hemodynamic or pleiotropism? 170
Do rebreathing manoeuvres for non-invasive measurement of cardiac output during maximum exercise test alter the main cardiopulmonary parameters? 169
Who let the clot out?: a case of mitral annulus thrombosis resolved by direct anticoagulants 169
Lvad pump speed increase is associated with increased peak exercise cardiac output and vo2, postponed anaerobic threshold and improved ventilatory efficiency 168
Sacubitril/Valsartan use in a real world experience : data from a large single-center population of heart failure patients with reduced ejection fraction 167
Surfactant proteins changes after acute hemodynamic improvement in patients with advanced chronic heart failure treated with Levosimendan 165
Effects of Sacubitril/Valsartan on exercise capacity, natriuretic peptides and ventricular remodeling in a prospective cohort of patients with heart failure and reduce ejection fraction 164
Massive right atrial thrombosis : are you brave enough to start anticoagulation? A case report 164
Effects of cardiac resynchronization therapy in heart failure patients 159
The importance of re-evaluating the risk score in heart failure patients: An analysis from the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score database 158
Acute Increase of Cardiac Output Reduces Central Sleep Apneas in Heart Failure Patients 156
Effects of sacubitril/Valsartan on exercise capacity, natriuretic peptides and ventricular remodelling in a prospective cohort of patients with heart failure and reduced ejection fraction 156
Plasma immature form of surfactant protein type B correlates with prognosis in patients with chronic heart failure : a pilot single-center prospective study 155
Why Levosimendan improves the clinical condition of patients with advanced heart failure : a holistic approach 155
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban 155
The double anaerobic threshold in heart failure: MECKI score database overview 153
Is red distribution width a valid tool to predict impaired iron transport in heart failure? 152
Effects of β-blockers on ventilation efficiency in heart failure 151
Multiparametric evalutation of percutaneous mitral valve repair (MitraClip) after 6 months 151
Contribution of central and peripheral factors at peak exercise in heart failure patients with progressive severity of exercise limitation 150
Qualitative and quantitative evaluation of a new wearable device for ECG and respiratory Holter monitoring 150
From kidney to kidney : an unusual case of paradoxical embolism through a patent foramen ovale in the course of a massive pulmonary embolism 149
Negative Effect of Biventricular Pacing on Right Ventricular Function: A Case Report 148
A Breathtaking Lift: Sex and Body Mass Index Differences in Cardiopulmonary Response in a Large Cohort of Unselected Subjects with Acute Exposure to High Altitude 148
Revisiting a Prognosticating Algorithm from Cardiopulmonary Exercise Testing in Chronic Heart Failure (from the MECKI Score Population) 146
Evidence of a double anaerobic threshold in healthy subjects 146
A case of myopericarditis recurrence after third dose of BNT162B2 vaccine against SARS-COV-2 in a young subject: link or casuality? 145
Iposideremia : ruolo patogeno 144
Una boccata d'ossigeno 144
Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy 144
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 143
From kidney to kidney: an unusual case of paradoxical embolism through a patent foramen ovale in the course of a massive pulmonary embolism- P1441 140
Validation of a new wearable device for type 3 sleep test without flowmeter 139
Rest and exercise oxygen uptake and cardiac output changes 6 months after successful transcatheter mitral valve repair 139
Effects of left ventricular assist device on cardiopulmonary exercise performance 138
Early cardiac reverse remodeling in a large cohort of patients with HFrEF treated with Sacubitril/Valsartan 138
A matter of sex—persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study 138
Cardiac patient care during a pandemic: how to reorganise a heart failure unit at the time of COVID-19 137
Symptomatic post COVID patients have impaired alveolar capillary membrane function and high VE/VCO2 136
Erectile dysfunction in heart failure: correlation with severity, exercise performance, comorbidities, and heart failure treatment 136
Comprehensive Assessment of Mitral Valve Geometry and Cardiac Remodeling With 3-Dimensional Echocardiography After Percutaneous Mitral Valve Repair 134
Infarct-like myocarditis in a patient with coronary artery disease presenting with chest pain: Looking beyond the simplest diagnosis 132
Sacubitril/valsartan can improve exercise performance in systolic chronic heart failure patients : a case report 131
Effects of sacubitril/valsartan on exercise capacity: a prognostic improvement that starts during uptitration 130
Effects of sacubitril/valsartan on cardiac performance and exercise capacity P998 128
Corrigendum to “Contribution of central and peripheral factors at peak exercise in heart failure patients with progressive severity of exercise limitation.” [Int. J. Cardiol. 248 (2017) 252–256] 127
Dapagliflozin effects on exercise, cardiac remodeling, biomarkers, and renal and pulmonary function in heart failure patients: not as good as expected? 124
The alveolar to arterial oxygen partial pressure difference is associated with pulmonary diffusing capacity in heart failure patients 124
Old therapies of new fashion: a better way to use diuretics and normal saline 124
Three-Dimensional Transthoracic Echocardiography in the Comprehensive Evaluation of Right and Left Heart Chamber Remodeling following Percutaneous Mitral Valve Repair 122
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 122
Peak exercise cardiac output but not oxygen uptake increases in all heart failure patients after successful resynchronization therapy 121
Chronotropic incompentence and functional capacity in chronic heart failure : no role of β-blockers and β-blocker dose 120
Cardiopulmonary exercise testing and heart failure: a tale born from oxygen uptake 119
Exercise in hypoxia: a model from laboratory to on field studies 117
The role of impaired iron transport on exercise performance and prognosis in patients with chronic heart failure 117
Pathophysiology of cardiorenal syndrome in decompensated heart failure: Role of lung-right heart-kidney interaction 116
Corrigendum to "Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database" [Int J Cardiol. 2020 Oct 15; 317: 103-110. PMID: 32360652] 115
Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction 112
Why do left ventricular assist device recipients remain heart failure patients? Reply 112
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation 111
Influence of exertional oscillatory breathing and its temporal behavior in patients with heart failure and reduced ejection fraction 110
Comprehensive effects of left ventricular assist device speed changes on alveolar gas exchange, sleep ventilatory pattern, and exercise performance 110
Roles of periodic breathing and isocapnic buffering period during exercise in heart failure 109
Accurate Fick cardiac output estimation: direct and simultaneous oxygen consumption measurement is imperative in heart failure 108
Oxygen Uptake during daily life domestic activities in patients with Heart Failure and reduced ejection fraction 107
Role of cardiopulmonary exercise test in the prediction of hemodynamic impairment in patients with pulmonary arterial hypertension 106
What about chronotropic incompetence in heart failure with mildly reduced ejection fraction? Clinical and prognostic implications from the MECKI score data-set 106
Multiparametric evaluation of percutaneous mitral valve repair (Mitraclip) after 3 months 106
Old therapies of new fashion: a better way to use diuretics and normal saline in acute decompensated heart failure 106
Totale 19.172
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.694
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021236 0 0 0 0 0 0 0 0 0 0 146 90
2021/20221.249 81 68 58 51 70 80 81 58 117 116 103 366
2022/20232.205 193 181 176 212 189 322 101 115 250 117 158 191
2023/20242.382 123 139 124 220 482 205 138 148 105 184 271 243
2024/20255.053 206 436 186 480 406 263 335 385 407 548 424 977
2025/20269.472 830 772 914 800 854 594 1.312 475 1.089 711 1.121 0
Totale 23.367